Current Applications for Overcoming Resistance to Targeted Therapies

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Szewczuk, Myron R. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Qorri, Bessi (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Sambi, Manpreet (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Σειρά: Resistance to Targeted Anti-Cancer Therapeutics, 20
• Θέματα: Cancer research.; Molecular biology.; Cancer Research.; Molecular Medicine.

Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. Howev...